Explore. Learn. Join the conversation.

Working Group on New TB Drugs

Stop TB Partnership

Video: Global Fund Impact in Indonesia

This video presents interviews with a diverse range of stakeholders on the positive impact that Global Fund financing has had for Indonesia’s national programme. This post also includes another perspective from Kenya.

TB R&D Weekly Update: Podcast Interview with Armand Van Deun

This week’s interview is with Dr. Armand Van Deun who was the recipient of the 2010 Stop TB Partnership-Kochon Foundation prize. Last year, Dr. Van Deun, et al., published an article in the American Journal of Respiratory and Critical Care Medicine entitled “Short, highly effective, and inexpensive standardized treatment of multidrug-resistant tuberculosis”. In the interview, we discuss this article which presents the results of an observational study in Bangladesh of a treatment for multidrug-resistant TB that incorporates fourth-generation fluoroquinolone combined with other second-line drugs and supplemented by potentially still active first-line drugs. Additional links to TB R&D News are included.

Announcement: World-Renowned Pulmonologist Michael Iseman Joins Oxford Immunotec

MIchael D. Iseman

Dr. Michael D. Iseman, a world renowned pulmonologist and leading expert on tuberculosis has joined Oxford Immunotec as the Senior Scientific Advisor. In May 2010, the WGND had the honor of interviewing Dr. Iseman in our “Voices from the Fight to Stop TB” series. We congratulate Dr. Iseman on is new position!

Podcast: Dr. Shelly Batra Working to Eliminate TB in India

podcast-thumb-ASHA

Shelly Batra is a renowned gyn & obs surgeon in New Delhi. She has a deep desire to serve the community. She has worked pro-bono for dissemination of medical information with many television stations and newspapers and written two books for Penguin Publishers.

Call to Action on Childhood TB

child-tb

The Stop TB Partnership has issued a Call to Action on Childhood TB. The call was an outcome of an international meeting organized jointly by the European Centre for Disease Prevention and Control (ECDC) and the Stop TB Partnership’s Childhood TB Subgroup in March. There was strong consensus among participants on the urgent need to make the voice of children heard through concerted advocacy efforts. Links are provided to information on the Call to Action and to a page where you can sign the Call to Action on Childhood TB. There are also links to previous coverage by the WGND on topics related to Childhood TB.

TB R&D Weekly Update: Podcast Interview with Dr. Edward Nardell

This week, we feature an interview with Dr. Edward Nardell who is a pulmonologist with a special interest in tuberculosis. His principal academic appointment is as associate professor of medicine, Harvard Medical School. In 2002 he joined Partners In Health as Director of Tuberculosis Research. During the interview, we discuss with Dr. Nardell his background and interest in TB, the Airbourne Infections Research (AIR) Facility, his thoughts on the MDR-TB epidemic, and his current research focus. Additional links to TB R&D News are included.

Interview with Dr. Mark Cotton – Part Two

mark-cotton-interview

Dr. Mark Cotton is Director of Children’s Infectious Diseases Clinical Research Unit (KID-CRU) at University of Stellenbosch in Cape Town, South Africa. Pediatric TB has emerged as a broad priority only in more recent years, though the University of Stellenbosch / Tygerberg Hospital team has been focusing on it for more than 20 years. This is part two of our interview with him.

TB R&D Weekly Update: Podcast Interview with Dr. Bernard Fourie

Dr. Bernard Fourie

The WGND had the opportunity to interview Dr. Bernard Fourie who is head of Medicine in Need-South Africa (MEND-SA).retoria, South Africa. In the interview, we discuss the ongoing projects at the Drug Research Laboratory at MEND-SA, a research and development center with the mission to developing and applying innovative approaches to the formulation and optimization of existing drugs for the treatment of tuberculosis. Additional links to TB R&D News are included.

TB R&D Weekly Update: Podcast interview on TB Drug Tolerance and Efflux Pumps

ramakrishnan

The WGND had the opportunity to interview three researchers (Lalita Ramakrishnan, Paul Edelstein, and Christine Cosma) involved in the groundbreaking research on the role of efflux pumps in contributing to drug tolerance during TB treatment which was published in the April 1 issue of Cell. Additional links to TB R&D News are included.

Interview with Dr. Mark Cotton – Part One

mark-cotton-interview

Dr. Mark Cotton is Director of Children’s Infectious Diseases Clinical Research Unit (KID-CRU) at University of Stellenbosch in Cape Town, South Africa. Pediatric TB has emerged as a broad priority only in more recent years, though the University of Stellenbosch / Tygerberg Hospital team has been focusing on it for more than 20 years.